(MENAFN- GlobeNewsWire - Nasdaq) The market is poised for growth (12.88% CAGR), driven by high demand for equipment due to capacity expansions, and the adoption of single-use systems, continuous ...

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

Continuous bioprocessing has emerged as a transformative approach in modern biomanufacturing, where integrated upstream and downstream operations enable uninterrupted production of biotherapeutics.

Disruptive innovation is the practice of reshaping a market or activity using novel processes and technologies. The idea has been around since the mid-90s, but it only started having a significant ...